Clinical Trials Browser

Phase 2 × NIH × Recurrent Uterine Sarcoma × Clear all

NCT00075400 2019-07-24

Imatinib Mesylate in Treating Patients With Recurrent or Persistent Uterine Cancer

Phase 2 Completed

26 enrolled 11 charts

GynecologicSarcoma

Recurrent Uterine Sarcoma

NCT01061606 2016-11-09

Temsirolimus in Treating Patients With Recurrent or Persistent Cancer of the Uterus

Phase 2 Terminated

8 enrolled 6 charts

GynecologicSarcoma

Recurrent Uterine Sarcoma

NCT00238121 2015-11-20

Sorafenib in Treating Patients With Advanced or Recurrent Uterine Cancer

Phase 2 Completed

56 enrolled 11 charts

GynecologicSarcoma

Recurrent Uterine Sarcoma